|1.||Oh, Se Heang: 5 articles (05/2015 - 03/2011)|
|2.||Lee, Jin Ho: 5 articles (05/2015 - 03/2011)|
|3.||Teoh, Swee-Hin: 4 articles (02/2015 - 01/2011)|
|4.||Amiji, Mansoor M: 4 articles (05/2008 - 12/2002)|
|5.||Lim, Jae-Young: 3 articles (05/2015 - 04/2013)|
|6.||Lee, Hye Seung: 3 articles (05/2015 - 04/2013)|
|7.||Kang, Sung-Bum: 3 articles (05/2015 - 04/2013)|
|8.||Lu, Jia: 3 articles (02/2015 - 01/2011)|
|9.||Han, Min: 3 articles (10/2014 - 01/2011)|
|10.||Mei, Lin: 3 articles (08/2014 - 06/2009)|
05/01/2013 - "Mammary cancer cells, MCF-7 cells, were cultured on 3D polycaprolactone (PCL) fibrous scaffolds, showing an increased proportion of CSCs. "
07/01/2014 - "We intend to fabricate natural ingredient or extract, and their combination loaded polycaprolactone (PCL) nanofibre for usage as drug-eluting stents or implants for anticancer activity against lung and breast cancers. "
03/01/2010 - "We report the efficacy of a therapeutic strategy that combines the potency of FP-PEA based on polycaprolactone (PCL) and low molecular weight polyethylenimine (LMW-PEI) with the tumor targeting potential of receptor mediated endocytosis. "
02/09/2015 - "In this study, we developed robust and tumor-targeted nanocarriers based on an amphiphilic hyaluronic acid (HA)-polycaprolactone (PCL) block copolymer, in which the HA shell was cross-linked via a bioreducible disulfide linkage. "
01/01/2011 - "In this study, we have developed a novel drug delivery system, ie, a polyethyleneglycol-polycaprolactone (PEG-PCL) copolymer micelle encapsulating doxorubicin, in order to circumvent drug resistance in adriamycin-resistant K562 tumor cells. "
05/01/2007 - "This study evaluates the efficacy of the spray-drying technique in the bioengineering of phenytoin (PHT) containing poly(epsilon-caprolactone) (PCL) microcarrier intended for brain delivery for long-term treatment of epilepsy. "
05/01/2007 - "Formulation of spray-dried phenytoin loaded poly(epsilon-caprolactone) microcarrier intended for brain delivery to treat epilepsy."
10/07/2015 - "The purpose of the study was to evaluate the anti-epileptic effects of injectable poly(epsilon-caprolactone) (PCL) microspheres for controlled release of an anticonvulsant, phenytoin (PHT), in an animal model of epilepsy. "
|3.||Wounds and Injuries (Trauma)
11/01/2014 - "Bio-conjugated polycaprolactone membranes: a novel wound dressing."
01/01/2007 - "In vivo evaluation of an ultra-thin polycaprolactone film as a wound dressing."
11/01/2014 - "This study evaluates the safety and efficacy of bio-conjugated polycaprolactone membranes (BPM) as a wound dressing. "
08/01/2015 - "Electrospun Polycaprolactone Membrane Incorporated with Biosynthesized Silver Nanoparticles as Effective Wound Dressing Material."
11/01/2013 - "The scaffold contained a helical outer shell consisting of porous microfilament coils of polycaprolactone (PCL) and biphasic calcium phosphates (BCP) that wound around a hollow electrospun PCL nanofibrous tube (the core). "
06/01/2003 - "Bioabsorbable rods of polycaprolactone are a safe and effective means of antibiotic delivery for treatment of osteomyelitis."
06/01/2003 - "The purpose of the current study was to show the efficacy and safety of an absorbable polymer (polycaprolactone) as an antibiotic delivery vehicle for treatment of osteomyelitis. "
07/01/2009 - "Cefoperazone sodium impregnated polycaprolactone composite implant for osteomyelitis."
01/01/2008 - "Antibiotic-loaded poly-epsilon-caprolactone and porous beta-tricalcium phosphate composite for treating osteomyelitis."
11/01/2001 - "Polycaprolactone had superior elution characteristics compared with polymethylmethacrylate in this lapine model, suggesting that polycaprolactone might be a promising local antibiotic delivery vehicle for the treatment of osteomyelitis."
|5.||Brucellosis (Malta Fever)
07/20/2001 - "A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice."
01/01/2008 - "In previous works, our research group has successfully proved the use of subcellular vaccines based on poly(epsilon-caprolactone) (PEC) microparticles containing an antigenic extract of Brucella ovis (HS) against experimental brucellosis in both mice and rams. "
01/01/2008 - "Stability of poly(epsilon-caprolactone) microparticles containing Brucella ovis antigens as a vaccine delivery system against brucellosis."
|2.||Ethylene Glycol (Monoethylene Glycol)
|5.||Poloxamer (Poloxamer 407)
|7.||bipiperidyl mustard (BPM)
|8.||Polyethylene Glycols (Polyethylene Glycol)
|9.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|5.||Blood Vessel Prosthesis